Inventor · disambiguated record
George C. Prendergast
Also filed as: PRENDERGAST GEORGE · PRENDERGAST GEORGE C
25 granted patents·15 pending applications·315 citations·filing 1995–2023
96Inventor score
Files withLANKENAU INST MEDICAL RES17WISTAR INST9PRENDERGAST GEORGE C5LAURY KLEINTOP LISA2AYENE IRAIMOUDI S1
Top patents by PatentIndex Score
40 records- 0196US8008281B2Methods for the treatment of cancerLANKENAU INST MEDICAL RES·Filed 2004·Granted Aug 30, 2011·92 cites·15 claims
- 0294US7705022B2IDO inhibitors and methods of use thereofLANKENAU INST MEDICAL RES·Filed 2006·Granted Apr 27, 2010·22 cites·12 claims
- 0392US8476454B2IDO inhibitors and methods of usePRENDERGAST GEORGE C·Filed 2010·Granted Jul 2, 2013·13 cites·8 claims
- 0488US8058416B2Nucleic acid molecules encoding indoleamine 2,3-dioxygenase-2PRENDERGAST GEORGE C·Filed 2008·Granted Nov 15, 2011·6 cites·5 claims
- 0585US8383613B2Methods for the treatment of cancerLANKENAU INST MEDICAL RES·Filed 2011·Granted Feb 26, 2013·7 cites·5 claims
- 0685US2024191212A1Nucleic Acid Molecules Encoding Indoleamine 2,3-Dioxygenase-2LANKENAU INST MEDICAL RES·Filed 2023·Application pending·0 cites
- 0784US7714139B2IDO inhibitors and methods of useLANKENAU INST FOR MEDCIAL RES·Filed 2004·Granted May 11, 2010·25 cites·9 claims
- 0884US6989383B1Method of treating cancerSLOAN KETTERING INST CANCER·Filed 1998·Granted Jan 24, 2006·63 cites·14 claims
- 0982US9879092B2Anti-RhoB antibodiesLAURY-KLEINTOP LISA·Filed 2012·Granted Jan 30, 2018·14 cites·7 claims
- 1082US6831063B1Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses thereforWISTAR INST·Filed 2000·Granted Dec 14, 2004·11 cites·5 claims
- 1181US8436151B2Indoleamine 2,3-dioxygenase-2 antibodiesPRENDERGAST GEORGE C·Filed 2011·Granted May 7, 2013·2 cites·3 claims
- 1279US11447568B2Methods and compositions for the treatment of ocular diseases and disordersLANKENAU INST MEDICAL RES·Filed 2015·Granted Sep 20, 2022·2 cites·8 claims
- 1379US8389568B2IDO inhibitors and methods of use thereofPRENDERGAST GEORGE C·Filed 2008·Granted Mar 5, 2013·4 cites·15 claims
- 1477USRE49708ENucleic acid molecules encoding indoleamine 2,3-dioxygenase-2LANKENAU INST MEDICAL RES·Filed 2021·Granted Oct 24, 2023·0 cites·8 claims
- 1575US7150968B2Bridging INtegrator-2 (Bin2) nucleic acid molecules and proteins and uses thereforWISTAR INST·Filed 2004·Granted Dec 19, 2006·4 cites·6 claims
- 1674US9174942B2IDO inhibitorsNEWLINK GENETICS CORP·Filed 2014·Granted Nov 3, 2015·2 cites·19 claims
- 1768US2013227719A1Indoleamine 2,3-Dioxygenase-2LANKENAU INST MEDICAL RES·Filed 2013·Application pending·0 cites
- 1868US2024374566A1Methods and compositions for the treatment of cancerLANKENAU INST FOR MEDICAL RESESARCH·Filed 2023·Application pending·0 cites
- 1966US11345747B2Methods and compositions for the treatment of diseases and disordersLANKENAU INST MEDICAL RES·Filed 2019·Granted May 31, 2022·0 cites·6 claims
- 2066US6048702AMurine and human box-dependent myc-interacting protein (Bin1) and uses thereforWISTAR INST·Filed 1997·Granted Apr 11, 2000·13 cites·24 claims
- 2160US5605830AMurine and human c-Myc interacting proteinWISTAR INST·Filed 1995·Granted Feb 25, 1997·11 cites·8 claims
- 2258US2013183388A1Novel IDO Inhibitors and Methods of Use ThereofLANKENAU INST MEDICAL RES·Filed 2013·Application pending·0 cites
- 2355US8586636B2Disulfide chemotherapeutic agents and methods of use thereofAYENE IRAIMOUDI S·Filed 2008·Granted Nov 19, 2013·0 cites·24 claims
- 2455US2003166021A1Box-dependent Myc-interacting protein (BIN1) compositions and uses thereforWISTAR INST·Filed 2002·Application pending·0 cites
- 2555US2020261414A1Methods and compositions for the treatment of cancerLANKENAU INST MEDICAL RES·Filed 2018·Application pending·0 cites
- 2654US6410238B1Box-dependent Myc-interacting protein (Bin1) compositions and uses thereofWISTAR INST·Filed 1998·Granted Jun 25, 2002·7 cites·10 claims
- 2752US9522164B2Disulfide chemotherapeutic agents and methods of use thereofLANKENAU INST MEDICAL RES·Filed 2013·Granted Dec 20, 2016·0 cites·10 claims
- 2852US2022364179A1Methods and compositions for assessing and predicting therapeutic responseLANKENAU INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 2949US10494424B2Methods and compositions for the treatment of diseases and disordersLANKENAU INST MEDICAL RES·Filed 2016·Granted Dec 3, 2019·0 cites·6 claims
- 3049US2022176011A1Scar reducing wound closure materialsLANKENAU INST MEDICAL RES·Filed 2020·Application pending·0 cites
- 3149US2024156795A1Methods and compositions for the treatment of drug resistant topical infectionsLANKENAU INST MEDICAL RES·Filed 2022·Application pending·0 cites
- 3248US2010166881A1Novel IDO Inhibitors and Methods of Use ThereofPRENDERGAST GEORGE C·Filed 2010·Application pending·0 cites
- 3346US2005137207A1Method of treating cancerFiled 2005·Application pending·0 cites
- 3445US2018094076A1Methods and Compositions for the Treatment of Autoimmune and Inflammatory DiseasesLAURY KLEINTOP LISA·Filed 2017·Application pending·0 cites
- 3544US5958753ANucleic acid sequences encoding Bau, a Bin1 interacting protein, and vectors and host cells containing sameWISTAR INST·Filed 1997·Granted Sep 28, 1999·7 cites·7 claims
- 3642US5723581AMurine and human box-dependent myc-interacting protein (Bin1)WISTAR INST·Filed 1996·Granted Mar 3, 1998·9 cites·3 claims
- 3739US2020200760A1Compositions comprising ligands to rhob protein and the uses thereofLANKENAU INSTITUTE OF MEDICAL RES·Filed 2018·Application pending·0 cites
- 3837US2019062452A1Methods and Compositions for the Treatment of Immunomodulatory Diseases and DisordersLANKENAU INST MEDICAL RES·Filed 2016·Application pending·0 cites
- 3936US6140465ABau, a BIN1 interacting protein, and uses thereforWISTAR INST·Filed 1999·Granted Oct 31, 2000·1 cites·2 claims
- 4036US2017008975A1Anti-Tissue Inhibitor of Metalloproteinase-4 (Timp-4) Antibodies and Methods of Use ThereofLANKENAU INST MEDICAL RES·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George C. Prendergast files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →